Market Overview:
The global PTCA coronary drug eluting balloons market is expected to grow at a CAGR of 10.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of coronary artery diseases, technological advancements in PTCA devices, and rising demand for minimally invasive procedures. Based on type, the global PTCA coronary drug eluting balloons market is segmented into DEB balloon and standard balloon. The DEB balloon segment is expected to grow at a higher CAGR than the standard balloon segment during the forecast period from 2018 to 2030. This growth can be attributed to the advantages offered by DEB balloons over standard balloons such as lower recoil force and reduced vessel trauma. Based on application, the global PTCA coronary drug eluting balloons market is divided into small vessel disease (SVD), bifurcation lesions, and others (including chronic total occlusions [CTOs], in-stent restenosis [ISRs], etc.). The SVD segment is estimated to account for a larger share of this market than other segments during the forecast period from 2018 to 2030 owingto its high prevalence across all regions studied in this research study.
Product Definition:
PTCA Coronary Drug Eluting Balloons, also known as drug eluting balloons, are medical devices that are used during percutaneous coronary intervention (PCI) procedures to help open blocked arteries. These balloons are coated with a medication that helps to keep the artery open after the balloon is removed. This can help reduce the risk of restenosis, or re-clogging of the artery.
DEB Balloon:
DEB balloon is a drug-eluting coronary stent, which is used in the treatment of complex and high-risk lesions. DEB balloon can be considered as an alternative to bare metal stents in such patients due to its better safety profile and reduced adverse effects. The introduction of new biodegradable materials for manufacturing DEBs has led to the development of bioabsorbable or biocompatible stents that are being increasingly adopted by healthcare professionals globally.
Standard Balloon:
The standard balloon is a part of the drug-eluting coronary stents and it is used to cover the bare metal stent. The size of this balloon ranges between 0.9mm to 1.8mm and its color depends on the type of polymer coating that has been applied on its surface (green, blue or red). It helps in reducing inflammation at the site of intervention by delivering drugs directly into the coronary artery without going through a blood vessel wall.
Application Insights:
The small vessel disease segment dominated the global PTCA coronary drug eluting balloons market in 2017 and is expected to maintain its dominance over the forecast period. This can be attributed to increasing awareness about early treatment of small-vessel disease, growing geriatric population susceptible to this condition, and availability of advanced products with improved designs that provide better stability and support.
Bifurcation lesions are expected to register a significant growth rate over the forecast period owing to rising incidence rates of heart diseases coupled with high mortality rates associated with this condition. Moreover, introduction of new products specifically designed for bifurcation lesions treatment is anticipated fuel industry growth during the study period.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, high adoption of PTCA devices and increasing government initiatives. The region is expected to maintain its dominance over the forecast period due to factors such as technological advancements, presence of well-established healthcare facilities and availability of skilled physicians.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising geriatric population, improving economic conditions & rapid development in healthcare infrastructure & services. Furthermore, an increase in awareness regarding various treatment options for coronary diseases will also support regional growth during the estimated time span.
The key players operating in this industry are Medtronic plc; Boston Scientific Corporation; Stryker Corporation; Zimmer Biomet Holdings Inc.; BMS Medical Products LLC.; Terumo BCT Corp.; Abbott Laboratories; AngioDynamics Holdings Inc., etc.
Growth Factors:
- Increasing incidence of coronary artery diseases (CAD) due to changing lifestyle and dietary habits.
- Growing geriatric population susceptible to CAD.
- Technological advancements in PTCA Coronary Drug Eluting Balloons that offer better clinical outcomes.
- Rising healthcare expenditure and insurance coverage for PTCA procedures in developed countries.
Scope Of The Report
Report Attributes
Report Details
Report Title
PTCA Coronary Drug Eluting Balloons Market Research Report
By Type
DEB Balloon, Standard Balloon
By Application
Small Vessel Disease, Bifurcation Lesions, Others
By Companies
B.Braun, Spectranetics, Concept Medical, Eurocor, Lifetech, Maxcor, Micell, Qualimed, Acrostak, B.Braun
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global PTCA Coronary Drug Eluting Balloons Market Report Segments:
The global PTCA Coronary Drug Eluting Balloons market is segmented on the basis of:
Types
DEB Balloon, Standard Balloon
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Small Vessel Disease, Bifurcation Lesions, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- B.Braun
- Spectranetics
- Concept Medical
- Eurocor
- Lifetech
- Maxcor
- Micell
- Qualimed
- Acrostak
- B.Braun
Highlights of The PTCA Coronary Drug Eluting Balloons Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DEB Balloon
- Standard Balloon
- By Application:
- Small Vessel Disease
- Bifurcation Lesions
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the PTCA Coronary Drug Eluting Balloons Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
PTCA coronary drug eluting balloons are a type of catheter that is inserted into the patient's artery to remove plaque from the arteries. The balloon is inflated with a small amount of air and then filled with a medication or device that causes the plaque to break down and fall out of the artery.
Some of the key players operating in the ptca coronary drug eluting balloons market are B.Braun, Spectranetics, Concept Medical, Eurocor, Lifetech, Maxcor, Micell, Qualimed, Acrostak, B.Braun.
The ptca coronary drug eluting balloons market is expected to grow at a compound annual growth rate of 10.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 PTCA Coronary Drug Eluting Balloons Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 PTCA Coronary Drug Eluting Balloons Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 PTCA Coronary Drug Eluting Balloons Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the PTCA Coronary Drug Eluting Balloons Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global PTCA Coronary Drug Eluting Balloons Market Size & Forecast, 2020-2028
4.5.1 PTCA Coronary Drug Eluting Balloons Market Size and Y-o-Y Growth
4.5.2 PTCA Coronary Drug Eluting Balloons Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 DEB Balloon
5.2.2 Standard Balloon
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Small Vessel Disease
6.2.2 Bifurcation Lesions
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global PTCA Coronary Drug Eluting Balloons Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 PTCA Coronary Drug Eluting Balloons Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 DEB Balloon
9.6.2 Standard Balloon
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Small Vessel Disease
9.10.2 Bifurcation Lesions
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 DEB Balloon
10.6.2 Standard Balloon
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Small Vessel Disease
10.10.2 Bifurcation Lesions
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 DEB Balloon
11.6.2 Standard Balloon
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Small Vessel Disease
11.10.2 Bifurcation Lesions
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 DEB Balloon
12.6.2 Standard Balloon
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Small Vessel Disease
12.10.2 Bifurcation Lesions
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 DEB Balloon
13.6.2 Standard Balloon
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Small Vessel Disease
13.10.2 Bifurcation Lesions
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 PTCA Coronary Drug Eluting Balloons Market: Competitive Dashboard
14.2 Global PTCA Coronary Drug Eluting Balloons Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 B.Braun
14.3.2 Spectranetics
14.3.3 Concept Medical
14.3.4 Eurocor
14.3.5 Lifetech
14.3.6 Maxcor
14.3.7 Micell
14.3.8 Qualimed
14.3.9 Acrostak
14.3.10 B.Braun
